Tonje K.A. Lissandrin

Forsker i biologi og immunologi, MBA, fagansvarlig

Biografi

Tonje K. A Lissandrin har jobbet som forsker i immunologi og infeksjonssykdommer ved Boston University School of Medicine og vært team leder for et større prosjekt innen tuberkulose under Harvard Medical School. Hun har hatt ansvaret for antibiotika-studier i AstraZeneca (USA). Hun har jobbet med terapi-analyser for GlaxoSmithKline (respiratoriske sykdommer, globalt).

Hun har MSc. -graden i Zoologi med spesialfelt immunologi. Hun har vært doktorgradsstipendiat (immunsystemet) ved universitetet i Lausanne (Sveits), og har MBA med æresgraden (London, UK). 

Tonje er forfatter på flere, vitenskapelige artikler i fagfellevurderte tidsskrifter:

• Perfusion 2002; 17: 15-21. Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass.

• Journal of Leukocyte Biology Supplement 2001 (Abstract 98 page 41). Roles of Toll-like Receptors in Immunity Against Mycobacteria.

• Experimental Biology April 20-24, 2002 (236.2 page 83). Roles of Toll like-receptors in immunity against mycobacterial infection.

• Journal of Leukocyte Biology 2003 74: 277-286. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. Cited by Harvard researchers.

• The Journal of Infectious Diseases2003; 188:320-326. Aspergillus fumigatus Evades Immune Recognition during Germination through Loss of Toll-Like Receptor-4 Mediated Signal Transduction.

• The Journal of Immunology, July 2008. Dynamic modulation of CCR7 expression and function on naïve T lymphocytes in vivo.

• CELL REPORTS, volume 21, Issue 9, November 2017. Perivascular Fibroblasts of the Developing Spleen Act as LTa1b2-Dependent Precursors of Both T and B Zone Organizer Cells.